Allogene Therapeutics (ALLO) Shares Outstanding (2018 - 2026)
Allogene Therapeutics (ALLO) Shares Outstanding (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 198.10 Mn |
| 10 | Allogene Therapeutics | 424.11 Mn | 424.11 Mn | - | 240.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 240.29 Mn |
| Dec 31, 2025 | 220.62 Mn |
| Sep 30, 2025 | 222.04 Mn |
| Jun 30, 2025 | 218.93 Mn |
| Mar 31, 2025 | 215.36 Mn |
| Dec 31, 2024 | 194.81 Mn |
| Sep 30, 2024 | 209.19 Mn |
| Jun 30, 2024 | 190.03 Mn |
| Mar 31, 2024 | 169.13 Mn |
| Dec 31, 2023 | 156.93 Mn |
| Sep 30, 2023 | 167.65 Mn |
| Jun 30, 2023 | 146.80 Mn |
| Mar 31, 2023 | 144.56 Mn |
| Dec 31, 2022 | 143.15 Mn |
| Sep 30, 2022 | 143.66 Mn |
| Jun 30, 2022 | 143.39 Mn |
| Mar 31, 2022 | 141.36 Mn |
| Dec 31, 2021 | 135.82 Mn |
| Sep 30, 2021 | 137.03 Mn |
| Jun 30, 2021 | 134.83 Mn |